Loading...
NPI 1194820662 · Portsmouth, NH · Dermatopathology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Stephen Brady is a dermatopathology physician provider located in Portsmouth, New Hampshire. This profile covers 5 Medicare and 1 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Stephen Brady |
| Address | 155 Borthwick Ave |
| City | Portsmouth |
| State | NH |
| ZIP | 03801 |
| Taxonomy | Dermatopathology Physician |
| NPI Enumerated | September 13, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $485.6K |
| Medicaid | $1.4K |
This provider’s billing is overwhelmingly Medicare-driven: total Medicare revenue is $485.6K compared with total Medicaid revenue of $1.4K, indicating an effectively single-payer, Medicare-dominant practice footprint rather than balanced dual-payer volumes. Medicaid activity is de minimis relative to Medicare and is concentrated in a single code, so overall commercial and Medicare trends will dominate financial performance.
Revenue concentration on Medicare is extreme: the precomputed top 3 Medicare codes by revenue account for 96.4% of this provider's total Medicare revenue, with 88305 alone representing 83.2% of Medicare dollars ($406.8K revenue from 7.3K claims at $56 avg paid/claim). This concentration signals material dependence on a small set of pathology services for the provider’s revenue base.
The code mix and descriptions point to a surgical pathology/dermatopathology workflow focused on high-volume surgical specimen interpretation and ancillary staining: 88305 (level IV surgical pathology review) dominates, while 88342 (initial single antibody stain) and 88312 (special stain for microorganisms) together provide most of the remaining Medicare revenue. These codes suggest the practice performs primary surgical pathology reads and interprets immunohistochemistry and special stains rather than broad clinical services.
Competitive standing on the highest-revenue Medicare code is strong: 88305 ranks #395 of 14580 providers nationally (97th percentile; notably above typical national volume), making the provider a high-volume national performer on that specific surgical pathology code. By contrast, the provider’s 88342 (451 claims, $36.1K revenue; ranks #806 of 11370 nationally, 93th percentile; typical, unremarkable volume) and 88312 (314 claims, $28.3K revenue; ranks #695 of 6966 nationally, 90th percentile; typical, unremarkable volume) positions are described as typical, indicating the standout competitive advantage is concentrated in 88305.
State-level Medicaid presence is minimal and concentrated: Medicaid revenue is $1.4K and is 100.0% attributable to 88305 (27 claims at $52 avg paid/claim), and that Medicaid 88305 activity ranks #39 of 41 providers in-state (5th percentile; typical, unremarkable volume for this code). This indicates the provider is not a major Medicaid pathology provider in New Hampshire and that Medicaid exposure is limited in scale.
Tenure and stability: the NPI was enumerated 2006-09-13 (~20 years ago), indicating a long-established practice record. That duration supports interpreting the observed code concentration as a stable, long-running operational pattern rather than a short-term fluctuation.
Code-level nuance beyond the top three: several additional pathology codes appear at much smaller revenue shares but with mixed comparative standing — for example, 88341 shows lower relative volume (158 claims, $10.7K revenue; ranks #6419 of 10274 nationally, 37th percentile; typical, unremarkable volume), while 88304 appears with modest revenue share (207 claims, $6.8K revenue) and is described as typical as well. These patterns underscore that revenue is narrowly focused on a few high-yield pathology services rather than diversified across many codes.
Operational and payer-risk implication: because a single code family (88305 and related staining codes) drives the majority of revenue, the provider’s financial performance is sensitive to changes in valuation, utilization policy, or payer edits affecting those pathology and immunohistochemistry codes. Analysts and contracting teams should treat shifts to reimbursement or clinical utilization for 88305/88342/88312 as disproportionately impactful for this provider.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
5 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 7,260 | $60 | $406.8K |
| 88342 | The lab analyst applies an initial single antibody stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a pathologist,… | 450 | $80 | $36.1K |
| 88312 | The lab analyst performs the technical lab steps to stain a specimen with a special stain. This code applies to Group I for microorganisms. A qualified provider, typically a pathologist, interprets… | 310 | $90 | $28.3K |
| 88341 | The lab analyst applies an additional single antibody stain on a slide or slides prepared from the same patient specimen as the initial antibody stain, such as tumor tissue. Then a qualified… | 160 | $70 | $10.7K |
| 88304 | The physician, typically a pathologist, performs a level III examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 210 | $30 | $6.8K |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 5 CPT/HCPCS codes.
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
1 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 30 | $50 | $1.4K |
How this provider's Medicaid billing volume and revenue compare to other New Hampshire providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. New Hampshire median
1 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 39 | 40 | 1,000 | $30 | $92.2K |
Other providers in the same ZIP code as Stephen Brady, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.